Republicans’ Drive To Tighten Immigration Overlooks Need For Doctors
Many areas in the U.S. depend on foreign doctors, but bitter political arguments over immigration have sown concerns about limited opportunities for these physicians.
The independent source for health policy research, polling, and news.
1,001 - 1,020 of 1,265 Results
Many areas in the U.S. depend on foreign doctors, but bitter political arguments over immigration have sown concerns about limited opportunities for these physicians.
The Trump administration gives states more flexibility to get around the health law’s requirements for insurance plans. But at the same time it wants employers to move millions of workers to the insurance exchanges.
Republicans seek to turn the tables on charges that they are undermining preexisting conditions, so they’re hammering the plans championed by some Democrats to expand Medicare.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
The new guidance allows states to ask for waivers from provisions in the Affordable Care Act governing not only subsidies, but also the benefits insurers must offer in all their plans.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.
Seema Verma, who heads the Centers for Medicare & Medicaid Services, tells private insurance officials that a push by some Democrats to expand Medicare would only increase troubles the program already faces.
Drug pricing is a top issue in the run-up to the midterm elections.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the Trump administration’s announcement that average premium prices are falling on the Obamacare marketplaces, the effort by Senate Democrats to reverse rules on short-term health insurance and the focus on protections for people with preexisting conditions in the run-up to midterm elections.
The Trump administration announces that the average price for insurance offered to people buying their own coverage on federal exchanges is going down.
Consumers favor ACA’s safeguards on the promise that patients who have health problems can get insurance. In the heat of the midterm campaigns, politicians in both parties agree, but their arguments don’t always add up.
Federal officials are proposing that Medicare pay doctors for a 10-minute “check-in” call with beneficiaries. But many doctors already do this for free, and the plan would require a cost-sharing charge of many patients.
Congress approved two bills last month that prohibit provisions keeping pharmacists from telling patients when they can save money by paying the cash price instead of the price negotiated by their insurance plan.
Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.
© 2026 KFF